SCHEMBL197513

SCHEMBL197513

[CH2]C1CCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3344209 1.00
SCHEMBL3340339 1.00
SCHEMBL197424 0.81
SCHEMBL1201554 0.81
SCHEMBL1201578 0.81
SCHEMBL4447672 0.79
SCHEMBL74345 0.79
SCHEMBL6264045 0.79
SCHEMBL4524525 0.77
Hydrochloric Acid SCHEMBL28179334 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 947 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 WO claimed
US-20230143583-A1 AMIDE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS AND METHODS OF TREATMENT TRANSLATIONAL DRUG DEVELOPMENT, LLC 2023-05-11 US claimed
CN-115803025-A Non-lysosomal glucosylceramidase inhibitors and uses thereof 阿勒克图治疗公司 2023-03-14 CN claimed
CN-115160295-A Amide compounds as kinase inhibitors 转化药物开发有限责任公司 2022-10-11 CN claimed
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US claimed
EP-3784226-A1 AMIDE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS AND METHODS OF TREATMENT TRANSLATIONAL DRUG DEVELOPMENT LLC (US) 2021-03-03 EP claimed
CN-112367982-A Amide compounds as kinase inhibitors, compositions and methods of treatment 转化药物开发有限责任公司 2021-02-12 CN claimed
US-10738007-B2 Amide compounds as kinase inhibitors, compositions and methods of treatment Translation Drug Development, LLC (US) 2020-08-11 US claimed
EP-3639824-A1 TRICYCLIC NITROGEN CONTAINING COMPOUNDS FOR TREATING NEISSERIA GONORRHOEA INFECTION GlaxoSmithKline Intellectual Property Development Limited (GB) 2020-04-22 EP claimed
US-20190248744-A1 AMIDE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS AND METHODS OF TREATMENT TRANSLATIONAL DRUG DEVELOPMENT, LLC 2019-08-15 US claimed
US-5705498-A Piperidine derivatives as 5-HT4 receptor antagonists SMITHKLINE BEECHAM PLC. (GB) 1998-01-06 US claimed
EP-0521827-B1 Pharmacological active hydrazin derivatives and process for their preparation CIBA GEIGY AG (CH) 1996-09-25 EP claimed
CN-1126472-A 5-HT4 receptor antagonists SMITHKLINE BEECHAM PLC (GB) 1996-07-10 CN claimed
EP-0699194-A1 5-HT4 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-03-06 EP claimed
EP-0684947-A1 AMIDE COMPOUNDS WITH PHARMACOLOGICAL ACTIVITY SMITHKLINE BEECHAM PLC (GB) 1995-12-06 EP claimed
EP-0667867-A1 PIPERIDINE DERIVATIVES AS 5-HT4 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1995-08-23 EP claimed
WO-1994027987-A1 5-HT4 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1994-12-08 WO claimed
CN-1092422-A Medicine SMITHKLINE BEECHAM PLC (GB) 1994-09-21 CN claimed
WO-1994019344-A1 AMIDE COMPOUNDS WITH PHARMACOLOGICAL ACTIVITY SMITHKLINE BEECHAM PLC (GB) 1994-09-01 WO claimed
WO-1994010174-A1 PIPERIDINE DERIVATIVES AS 5-HT4 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1994-05-11 WO claimed